Why See Yourself Health?
For Payors
$1 out of every $4 in US health care costs is spent caring for people with diabetes. Annually, diabetes costs the United States healthcare system over $237 billion annually in direct medical claims, which burden federal and commercial payors alike.
In addition to these direct diabetes costs, most of the high-cost claim categories that insurers face are exacerbated when a patient also lives with under-managed diabetes. With our HOPE Platform, we give participants the tools to become high-performing drivers of care and diabetes management.
The Evidence
Our results put SYH’s HOPE Platform in a rare class of technology-enabled solutions with the potential to increase patient engagement and adherence to chronic disease self-management behaviors, and therefore reduce the total cost of diabetes care by reducing acute and chronic complications that lead to avoidable health system use (the major driver of diabetes care costs).
We believe that we have the potential to drive enormous commercial impact, in particular because of our proven ability to engage and manage patients from high-risk groups such as older adults, low-income individuals and those with a high burden of unmet social needs. Table 1 is an example of annualized return-on-investment (ROI) estimator for a real-world sample of adult patients with T2DM with A1c>8% at baseline and average reduction after 12 weeks of DSME of 0.5%. In this ROI estimation, each 1% reduction in A1c is estimated to lead to $16000 in cost saving based on proprietary data from a healthcare payor advisor.
